PartnerTech signs framework agreement with Dignitana AB (publ)

Contract manufacturer PartnerTech AB and Dignitana AB (publ), a company focusing on medical devices in the area of medical cooling, today announced the signing of a framework agreement for the development, manufacturing and supply of products to Dignitana AB.

Initially, the agreement will focus on the DigniCapTMSystem, a patented scalp cooling system which prevents chemotherapy induced hair loss. The agreement covers the full scale of PartnerTech's competences within electronics, mechanics, systems integration and enclosures, and production will initially cover enclosures delivered from PartnerTech's unit in Åtvidaberg, Sweden. Revenue and the first deliveries from this agreement are expected in the third quarter 2012.

Dignitana has during the last year signed on two major international healthcare partners, Konica Minolta MG and Sysmex Europe GmbH, a subsidiary of Sysmex Corporation, and will substantially increase the level of production to meet the demand from the market and their partners.

" We have been working very close with Dignitana and one of their partners in the implementation of improvements and preparation for start-up of production of the DigniCapTMSystem. Dignitana is an innovative company, both in terms of technology and business development, and we are very pleased that they have chosen PartnerTech as a key partner for the long term development and production of their products," says PartnerTech President and CEO Leif Thorwaldsson.

"The next phase of Dignitana starts now, having established a solid industrial platform. Since more than a year back we have been working with the team at PartnerTech in different projects and, in close cooperation with and influenced by our two key Japanese partners, we have established a long term partnership with PartnerTech both for production and development", says Martin Waleij, CEO Dignitana.

For more information, please contact:

Leif Thorwaldsson, President and CEO, PartnerTech AB , Tel: +46 (0) 40 10 26 41

Martin Waleij, CEO Dignitana AB, Tel: +46 - 733 93 70 76

PartnerTech

PartnerTech develops and manufactures products under contract for leading companies, primarily in Information Technology, Industry, CleanTech, MedTech and Instrumentation, Defense and Maritime and Point of Sale Applications. With approximately 1,300 employees at its plants in Sweden, Norway, Finland, Poland, the UK, the United States and China PartnerTech reports annual sales of more than SEK 2,3 billion. PartnerTech AB (www.partnertech.com), the parent company, has its head office in Vellinge, Sweden, and is listed on the Nasdaq OMX Stockholm Exchange.

PartnerTech AB, corporate identity number 556251-3308

Box 103, Industrigatan 2, SE-235 22 Vellinge, Sweden

PartnerTech (publ) is required to publicly disclose the information in this press release pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for public disclosure at 11 a.m. on August 20th, 2012.

Dignitana

Dignitana AB, listed on the OMX First North Stockholm, focuses on patented invention DigniCap™ system , a medical device for preventing hair-loss in chemotherapy patients throug

Dignitana installs the first DigniCap Delta Scalp Cooling System in Rome

Dignitana ABmanufacturer of The DigniCap® Scalp Cooling System, has announced installation of the first DigniCap Delta at the prestigious Gemelli University Hospital in Rome, Italy last month.


Dignitana Promotes Scalp Cooling at Supportive Care Conference

Dignitana ABworld leader in clinically superior scalp cooling technology, is co-sponsoring a scalp cooling session at the Multinational Association for Supportive Care in Cancer (MASCC) Annual Meeting, held June 21 - 23 in San Francisco, California.


Kommuniké från Dignitana AB årsstämma 2019

Dignitana AB, tillverkare av Dignicap®scalp Cooling system, höll idag årsstämma i bolagets lokaler på traktorgränden 3 i Lund. Stämman beslutade i enlighet med samtliga förslag som styrelsen och aktieägare lagt fram. Nedan följer en sammanfattning av de beslut som fattats. 


Communication from the Dignitana AB Annual General Meeting 2019

Dignitana AB, manufacturer of The DigniCap® Scalp Cooling System, has today held an Annual General Meeting at the company's premises at Traktorgränden 3 in Lund. In all the proposed cases, the AGM resolved in accordance with the Board's proposal. Below is a summary of the decisions taken. 


Dignitana AB Publishes Q1 2019 Interim Report

Results and financial position

Significant events during the period

  • Sales and other income for the period amounted to 10,106 TSEK, $1,102 KUSD, an increase of 69 percent compared to the same period in 2018 and a15 percent quarter over quarter growth compared to fourth quarter 2018.
  • EBITDA amounted to (2,799) TSEK, ($305) KUSD, a 59 percent improvement compared to the same period in 2018.
  • Contracts were signed for 22 locations globally, bringing the total number of sites in the U.S. to 125 in 29 states at the close of first quarter.
  • Dignitana announced receipt of CE Marking approval for European sales of the new DigniCap Delta device.
  • As a result of the rights and directed equity issues in December, Dignitana now has 48,599,155 shares registered at Swedish Companies Registration Office.
  • Dignitana announced a partnership with oneservice GmbH, a global provider of specialty technical services, to provide service and maintenance to facilities offering DigniCap in Europe.

Dignitana Leadership Efforts Prompt Landmark Legislation

Dignitana AB (publ)manufacturer of The DigniCap® Scalp Cooling System, announces that HB3984, the bill providing coverage for scalp cooling that the company initiated in February with Texas State legislators, was passed in the Texas House of Representatives on Friday. The Bill now moves to the Senate where it will be introduced by Sen. Angela Paxton. Once passed in the Senate, the Bill then requires approval by Texas Governor Greg Abbott before being signed into law.


Kallelse till årsstämma i Dignitana AB (publ)

Aktieägarna i Dignitana AB (publ), 556730-5346("Bolaget") kallas härmed till årsstämma onsdag den 15 maj 2019 kl. 9.00 i Bolagets lokaler, Traktorgränden 3, i Lund.


Notice of Annual General Meeting of Dignitana AB (publ)

Aktieägarna i Dignitana AB (publ), 556730-5346("Bolaget") kallas härmed till årsstämma onsdag den 15 maj 2019 kl. 9.00 i Bolagets lokaler, Traktorgränden 3, i Lund.


Rättelse: Felaktig MAR-klassificering i tidigare pressmeddelande

Dignitana AB issues a rättelse i pressmeddelande "Dignitana AB publicerar årsredovisningen för 2018." Rättelsen avser att pressmeddelandet var felaktigt klassat som MAR och innehöll därför stycket som följer:


Correction: Incorrect MAR Classification in previous press release

Dignitana AB issues a correction in press release "Dignitana AB publishes the annual report for 2018." The correction means that the press release was incorrectly classified as MAR and therefore contained the paragraph as follows:


Dignitana AB publicerar årsredovisningen för 2018

Lund, Sweden - 12 April 2019 - Dignitana AB offentliggör härmed årsredovisningen avseende 2018. Årsredovisningen finns som bilaga till detta pressmeddelande samt går att ladda ner från hemsidan, www.dignitana.se. Det går även att beställa en utskriven version via investorrelations@dignitana.com.


Dignitana AB Publishes Annual Report for 2018

Lund, Sweden - 12 April 2019 - Dignitana AB hereby publishes the annual report for 2018. The Annual Report is attached to this press release and will be posted today on the Dignitana website. You can also order a printed version via investorrelations@dignitana.com.


Dignitana AB Receives CE Marking for Next Generation DigniCap Delta to Reduce Hair Loss from Chemotherapy

Dignitana AB (publ), manufacturer of The DigniCap® Scalp Cooling System, today announced receiving CE Marking approval for European sales of DigniCap Delta, the next generation scalp cooling device. An advanced and redesigned model of the 2015 FDA-cleared DigniCap Scalp Cooling System, DigniCap Delta features a new single patient use cap system consisting of a flexible Cooling Wrap and an adjustable Thermal Cap to optimize scalp cooling outcomes and ease-of-use for patients and nurses. The streamlined DigniCap Delta is 54 percent smaller than the current model and the intuitive interface provides up to 80 percent reduction in nursing time per patient infusion versus the existing device.


Dignitana CEO William Cronin to Speak at Aktiedagen Stockholm

Dignitana AB announces that Chief Executive Officer William Cronin will speak at Aktiedagen Stockholm on 19 March 2019 at 15:00 CET.


Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Sturegatan 32
114 36 Stockholm

08-692 21 90
Kontaktformulär